Effects of developmental exposure to manganese and/or low iron diet: Changes to metal transporters, sucrose preference, elevated zero-maze, open-field, and locomotion in response to fenfluramine, amphetamine, and MK-801

Toxicology Reports

Volumn 2, Issue , 2015, Pages 1046-1056

  Amos Kroohs, Robyn M ^a,b   Bloor, Colin P ^a,b   Qureshi, Momina A ^a,b   Vorhees, Charles V ^a,b   Williams, Michael T ^a,b  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Iron; Manganese; Preweaning development; Rat

Indexed keywords

AMPHETAMINE; DIZOCILPINE; FENFLURAMINE; IRON; MANGANESE; MEMBRANE PROTEIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; TRANSFERRIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; ZRT IRT LIKE PROTEIN 8;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CONTROLLED STUDY; DEVELOPMENTAL TOXICITY; ELEVATED ZERO MAZE TEST; FEMALE; HIPPOCAMPUS; IMMUNOREACTIVITY; IRON RESTRICTION; LOCOMOTION; MALE; MORTALITY; NEOSTRIATUM; NONHUMAN; OPEN FIELD TEST; RAT; SUCROSE PREFERENCE TEST; WESTERN BLOTTING;

EID: 84938723262     PISSN: 22147500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxrep.2015.07.015     Document Type: Article

References (80)

1. Anderson J.G., Fordahl S.C., Cooney P.T., Weaver T.L., Colyer C.L., Erikson K.M. Extracellular norepinephrine, norepinephrine receptor and transporter protein and mRNA levels are differentially altered in the developing rat brain due to dietary iron deficiency and manganese exposure. Brain Res. 2009, 1281:1-14.
2. Arcangeli T., Thilaganathan B., Hooper R., Khan K.S., Bhide A. Neurodevelopmental delay in small babies at term: a systematic review. Ultrasound Obstet. Gynecol. 2012, 40:267-275.
3. Aschner M., Aschner J.L. Manganese transport across the blood-brain barrier: relationship to iron homeostasis. Brain Res. Bull. 1990, 24:857-860.
4. Aulakh C.S., Wozniak K.M., Hill J.L., Murphy D.L. Long-term imipramine treatment differentially affects fenfluramine-induced suppression of food intake and locomotor activity. Pharmacol. Biochem. Behav. 1988, 31:97-101.
5. Bellinger D.C. Prenatal exposures to environmental chemicals and children's neurodevelopment: an update. Saf. Health Work 2013, 4:1-11.
6. Benedetto A., Au C., Aschner M. Manganese-induced dopaminergic neurodegeneration: insights into mechanisms and genetics shared with Parkinson's disease. Chem. Rev. 2009, 109:4862-4884.
7. Benedetto A., Au C., Avila D.S., Milatovic D., Aschner M. Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans. PLoS Genet. 2010, 6.
8. Bermejo F., Garcia-Lopez S. A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases. World J. Gastroenterol. 2009, 15:4638-4643.
9. Black M.M., Quigg A.M., Hurley K.M., Pepper M.R. Iron deficiency and iron-deficiency anemia in the first two years of life: strategies to prevent loss of developmental potential. Nutr. Rev. 2011, 69:S64-S70. Suppl. 1.
10. Blass E.M., Teicher M.H. Suckling Sci. 1980, 210:15-22.
11. Bouchard M., Laforest F., Vandelac L., Bellinger D., Mergler D. Hair manganese and hyperactive behaviors: pilot study of school-age children exposed through tap water. Environ. Health Perspect. 2007, 115:122-127.
12. Bouchard M.F., Sauve S., Barbeau B., Legrand M., Brodeur M.E., Bouffard T., Limoges E., Bellinger D.C., Mergler D. Intellectual impairment in school-age children exposed to manganese from drinking water. Environ. Health Perspect. 2011, 119:138-143.
13. Braun A.A., Skelton M.R., Vorhees C.V., Williams M.T. Comparison of the elevated plus and elevated zero mazes in treated and untreated male Sprague-Dawley rats: effects of anxiolytic and anxiogenic agents. Pharmacol. Biochem Behav. 2011, 97:406-415.
14. Braun A.A., Graham D.L., Schaefer T.L., Vorhees C.V., Williams M.T. Dorsal striatal dopamine depletion impairs both allocentric and egocentric navigation in rats. Neurobiol. Learn. Mem. 2012, 97:402-408.
15. Bristow L.J., Hutson P.H., Thorn L., Tricklebank M.D. The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents. Br. J. Pharmacol. 1993, 108:1156-1163.
16. De-Regil L.M., Jefferds M.E., Sylvetsky A.C., Dowswell T. Intermittent iron supplementation for improving nutrition and development in children under years of age. Cochrane Database Syst. Rev. 2011, 12:CD009085.
17. Dobson A.W., Erikson K.M., Aschner M. Manganese neurotoxicity. Ann. N Y. Acad. Sci. 2004, 1012:115-128.
18. Erikson K.M., John C.E., Jones S.R., Aschner M. Manganese accumulation in striatum of mice exposed to toxic doses is dependent upon a functional dopamine transporter. Environ. Toxicol. Pharmacol. 2005, 20:390-394.
19. Erikson K.M., Shihabi Z.K., Aschner J.L., Aschner M. Manganese accumulates in iron-deficient rat brain regions in a heterogeneous fashion and is associated with neurochemical alterations. Biol. Trace Elem. Res. 2002, 87:143-156.
20. Erikson K.M., Thompson K., Aschner J., Aschner M. Manganese neurotoxicity: a focus on the neonate. Pharmacol. Ther. 2007, 113:369-377.
21. Fechter L.D. Distribution of manganese in development. Neurotoxicology 1999, 20:197-201.
22. Fitsanakis V.A., Au C., Erikson K.M., Aschner M. The effects of manganese on glutamate, dopamine and gamma-aminobutyric acid regulation. Neurochem. Int. 2006, 48:426-433.
23. Fitsanakis V.A., Thompson K.N., Deery S.E., Milatovic D., Shihabi Z.K., Erikson K.M., Brown R.W., Aschner M. A chronic iron-deficient/high-manganese diet in rodents results in increased brain oxidative stress and behavioral deficits in the morris water maze. Neurotox. Res. 2009, 15:167-178.
24. Fitsanakis V.A., Zhang N., Anderson J.G., Erikson K.M., Avison M.J., Gore J.C., Aschner M. Measuring brain manganese and iron accumulation in rats following 14 weeks of low-dose manganese treatment using atomic absorption spectroscopy and magnetic resonance imaging. Toxicol. Sci. 2008, 103:116-124.
25. Fitsanakis V.A., Zhang N., Avison M.J., Erikson K.M., Gore J.C., Aschner M. Changes in dietary iron exacerbate regional brain manganese accumulation as determined by magnetic resonance imaging. Toxicol. Sci. 2011, 120:146-153.
26. Fletcher P.J., Sinyard J., Higgins G.A. The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists. Psychopharmacology (Berl) 2006, 187:515-525.
27. Garcia S.J., Gellein K., Syversen T., Aschner M. A manganese-enhanced diet alters brain metals and transporters in the developing rat. Toxicol. Sci. 2006, 92:516-525.
28. Grace C.E., Schaefer T.L., Graham D.L., Skelton M.R., Williams M.T., Vorhees C.V. Effects of inhibiting neonatal methamphetamine-induced corticosterone release in rats by adrenal autotransplantation on later learning, memory, and plasma corticosterone levels. Int. J. Dev. Neurosci. 2010.
29. Graham D.L., Amos-Kroohs R.M., Braun A.A., Grace C.E., Schaefer T.L., Skelton M.R., Williams M.T., Vorhees C.V. Neonatal (+)-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists. Int. J. Neuropsychopharmacol. 2012, 16:377-391.
30. Graham D.L., Grace C.E., Braun A.A., Schaefer T.L., Skelton M.R., Tang P.H., Vorhees C.V., Williams M.T. Effects of developmental stress and lead (Pb) on corticosterone after chronic and acute stress, brain monoamines, and blood Pb levels in rats. Int. J. Dev. Neurosci. 2011, 29:45-55.
31. Guilarte T.R., Chen M.K. Manganese inhibits NMDA receptor channel function: implications to psychiatric and cognitive effects. Neurotoxicology 2007, 28:1147-1152.
32. Guilarte T.R., Chen M.K., McGlothan J.L., Verina T., Wong D.F., Zhou Y., Alexander M., Rohde C.A., Syversen T., Decamp E., Koser A.J., Fritz S., Gonczi H., Anderson D.W., Schneider J.S. Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates. Exp. Neurol. 2006, 202:381-390.
33. Gulley J.M., Stanis J.J. Adaptations in medial prefrontal cortex function associated with amphetamine-induced behavioral sensitization. Neuroscience 2010, 166:615-624.
34. He L., Girijashanker K., Dalton T.P., Reed J., Li H., Soleimani M., Nebert D.W. ZIP8, member of the solute-carrier-39 (SLC39) metal-transporter family: characterization of transporter properties. Mol. Pharmacol. 2006, 70:171-180.
35. Hunt J.R., Zito C.A., Erjavec J., Johnson L.K. Severe or marginal iron deficiency affects spontaneous physical activity in rats. Am. J. Clin. Nutr. 1994, 59:413-418.
36. Karki P., Lee E., Aschner M. Manganese neurotoxicity: a focus on glutamate transporters. Ann. Occup. Environ. Med. 2013, 25:4.
37. Kern C.H., Smith D.R. Preweaning Mn exposure leads to prolonged astrocyte activation and lasting effects on the dopaminergic system in adult male rats. Synapse 2011, 65:532-544.
38. Kern C.H., Stanwood G.D., Smith D.R. Preweaning manganese exposure causes hyperactivity, disinhibition, and spatial learning and memory deficits associated with altered dopamine receptor and transporter levels. Synapse 2010, 64:363-378.
39. Khan K., Factor-Litvak P., Wasserman G.A., Liu X., Ahmed E., Parvez F., Slavkovich V., Levy D., Mey J., van G.A., Graziano J.H. Manganese exposure from drinking water and children's classroom behavior in Bangladesh. Environ. Health Perspect. 2011, 119:1501-1506.
40. Khan K., Wasserman G.A., Liu X., Ahmed E., Parvez F., Slavkovich V., Levy D., Mey J., van G.A., Graziano J.H., Factor-Litvak P. Manganese exposure from drinking water and children's academic achievement. Neurotoxicology 2012, 33:91-97.
41. Kim J., Buckett P.D., Wessling-Resnick M. Absorption of manganese and iron in a mouse model of hemochromatosis. PLoS ONE 2013, 8:e64944.
42. Kim Y., Lee B.K. Iron deficiency increases blood manganese level in the Korean general population according to KNHANES 2008. Neurotoxicology 2011, 32:247-254.
43. Kontur P.J., Fechter L.D. Brain regional manganese levels and monoamine metabolism in manganese-treated neonatal rats. Neurotoxicol. Teratol. 1988, 10:295-303.
44. Kwik-Uribe C.L., Gietzen D., German J.B., Golub M.S., Keen C.L. Chronic marginal iron intakes during early development in mice result in persistent changes in dopamine metabolism and myelin composition. J. Nutr. 2000, 130:2821-2830.
45. Kwik-Uribe C.L., Golub M.S., Keen C.L. Chronic marginal iron intakes during early development in mice alter brain iron concentrations and behavior despite postnatal iron supplementation. J. Nutr. 2000, 130:2040-2048.
46. Kwik-Uribe C.L., Golubt M.S., Keen C.L. Behavioral consequences of marginal iron deficiency during development in a murine model. Neurotoxicol. Teratol. 1999, 21:661-672.
47. Lee A.I., Okam M.M. Anemia in pregnancy. Hematol. Oncol. Clin. North Am. 2011, 25:241-259. vii.
48. Lesch K.P., Waider J. Serotonin in the modulation of neural plasticity and networks: implications for neurodevelopmental disorders. Neuron 2012, 76:175-191.
49. Lozoff B. Early iron deficiency has brain and behavior effects consistent with dopaminergic dysfunction. J. Nutr. 2011, 141:740S-746S.
50. Lucchini R.G., Guazzetti S., Zoni S., Donna F., Peter S., Zacco A., Salmistraro M., Bontempi E., Zimmerman N.J., Smith D.R. Tremor, olfactory and motor changes in Italian adolescents exposed to historical ferro-manganese emission. Neurotoxicology 2012, 33:687-696.
51. Mena I., Court J., Fuenzalida S., Papavasiliou P.S., Cotzias G.C. Modification of chronic manganese poisoning. Treatment with l-dopa or 5-OH tryptophane. N. Engl. J. Med. 1970, 282:5-10.
52. Mena I., Marin O., Fuenzalida S., Cotzias G.C. Chronic manganese poisoning. Clinical picture and manganese turnover. Neurology 1967, 17:128-136.
53. Menezes-Filho J.A., Bouchard M., Sarcinelli P.N., Moreira J.C. Manganese exposure and the neuropsychological effect on children and adolescents: a review. Rev. Panam. Salud Publica 2009, 26:541-548.
54. Molina R.M., Phattanarudee S., Kim J., Thompson K., Wessling-Resnick M., Maher T.J., Brain J.D. Ingestion of Mn and Pb by rats during and after pregnancy alters iron metabolism and behavior in offspring. Neurotoxicology 2011, 32:413-422.
55. Pappas B.A., Zhang D., Davidson C.M., Crowder T., Park G.A., Fortin T. Perinatal manganese exposure: behavioral, neurochemical, and histopathological effects in the rat. Neurotoxicol. Teratol. 1997, 19:17-25.
56. Rahman M.A., Rahman B., Ahmed N. High blood manganese in iron-deficient children in Karachi. Public Health Nutr. 2013, 16:1677-1683.
57. Redman R.S., Sweney L.R. Changes in diet and patterns of feeding activity of developing rats. J. Nutr. 1976, 106:615-626.
58. Redmond A.M., Harkin A., Kelly J.P., Leonard B.E. Effects of acute and chronic antidepressant administration on phencyclidine (PCP) induced locomotor hyperactivity. Eur. Neuropsychopharmacol. 1999, 9:165-170.
59. Roth J.A., Garrick M.D. Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese. Biochem. Pharmacol. 2003, 66:1-13.
60. Smith E.A., Newland P., Bestwick K.G., Ahmed N. Increased whole blood manganese concentrations observed in children with iron deficiency anaemia. J. Trace Elem. Med. Biol. 2013, 27:65-69.
61. Suzuki K. Special vulnerabilities of the developing nervous system. Experimental and Clinical Neurotoxicology 1980, 48-61. Williams and Wilkens, Baltimore. P.S. Spencer, H.H. Schaumburg (Eds.).
62. Takeda A., Ishiwatari S., Okada S. Manganese uptake into rat brain during development and aging. J. Neurosci. Res. 1999, 56:93-98.
63. Thompson K., Molina R.M., Donaghey T., Schwob J.E., Brain J.D., Wessling-Resnick M. Olfactory uptake of manganese requires DMT1 and is enhanced by anemia. FASEB J. 2007, 21:223-230.
64. Tran T.T., Chowanadisai W., Crinella F.M., Chicz-Demet A., Lonnerdal B. Effect of high dietary manganese intake of neonatal rats on tissue mineral accumulation, striatal dopamine levels, and neurodevelopmental status. Neurotoxicology 2002, 23:635-643.
65. Tran T.T., Chowanadisai W., Lonnerdal B., Le L., Parker M., Chicz-Demet A., Crinella F.M. Effects of neonatal dietary manganese exposure on brain dopamine levels and neurocognitive functions. Neurotoxicology 2002, 23:645-651.
66. Tuschl K., Mills P.B., Clayton P.T. Manganese and the brain. Int. Rev. Neurobiol. 2013, 110:277-312.
67. Unger E.L., Paul T., Murray-Kolb L.E., Felt B., Jones B.C., Beard J.L. Early iron deficiency alters sensorimotor development and brain monoamines in rats. J. Nutr. 2007, 137:118-124.
68. Vorhees C.V., Graham D.L., Amos-Kroohs R.M., Braun A.A., Grace C.E., Schaefer T.L., Skelton M.R., Erikson K.M., Aschner M., Williams M.T. Effects of developmental manganese, stress, and the combination of both on monoamines, growth, and corticosterone. Toxicol. Rep. 2014, 1:1046-1061.
69. Vorhees C.V., Graham D.L., Braun A.A., Schaefer T.L., Skelton M.R., Richtand N.M., Williams M.T. Prenatal immune challenge in rats: altered responses to dopaminergic and glutamatergic agents, prepulse inhibition of acoustic startle, and reduced route-based learning as a function of maternal body weight gain after prenatal exposure to poly IC. Synapse 2012, 66:725-737.
70. Vorhees C.V., Graham D.L., Braun A.A., Schaefer T.L., Skelton M.R., Richtand N.M., Williams M.T. Prenatal immune challenge in rats: effects of polyinosinic-polycytidylic acid on spatial learning, prepulse inhibition, conditioned fear, and responses to MK-801 and amphetamine. Neurotoxicol. Teratol. 2015, 47:54-65.
71. Vorhees C.V., Herring N.R., Schaefer T.L., Grace C.E., Skelton M.R., Johnson H.L., Williams M.T. (2008) Effects of neonatal (+)-methamphetamine on path integration and spatial learning in rats: effects of dose and rearing conditions. Int. J. Dev. Neurosci. 2008, 26:599-610.
72. Wang S.H., Zhang Z.J., Guo Y.J., Zhou H., Teng G.J., Chen B.A. Anhedonia and activity deficits in rats: impact of post-stroke depression. J. Psychopharmacol. 2009, 23:295-304.
73. Wang X., Miller D.S., Zheng W. Intracellular localization and subsequent redistribution of metal transporters in a rat choroid plexus model following exposure to manganese or iron. Toxicol. Appl. Pharmacol. 2008, 230:167-174.
74. Wasserman G.A., Liu X., Parvez F., Ahsan H., Levy D., Factor-Litvak P., Kline J., van G.A., Slavkovich V., Loiacono N.J., Cheng Z., Zheng Y., Graziano J.H. Water manganese exposure and children's intellectual function in Araihazar, Bangladesh. Environ. Health Perspect. 2006, 114:124-129.
75. WHO World Health Organization (WHO): Micronutrient Deficiencies 2015, Iron deficiency anemia.
76. Williams B.B., Kwakye G.F., Wegrzynowicz M., Li D., Aschner M., Erikson K.M., Bowman A.B. Altered manganese homeostasis and manganese toxicity in a Huntington's disease striatal cell model are not explained by defects in the iron transport system. Toxicol. Sci. 2010, 117:169-179.
77. Yoon M., Schroeter J.D., Nong A., Taylor M.D., Dorman D.C., Andersen M.E., Clewell H.J., III Physiologically based pharmacokinetic modeling of fetal and neonatal manganese exposure in humans: describing manganese homeostasis during development. Toxicol. Sci. 2011, 122:297-316.
78. Zack M., Featherstone R.E., Mathewson S., Fletcher P.J. Chronic exposure to a gambling-like schedule of reward predictive stimuli can promote sensitization to amphetamine in rats. Front. Behav. Neurosci. 2014, 8. 36.
79. Zhang G., Liu D., He P. Effects of manganese on learning abilities in school children. Zhonghua Yu Fang Yi Xue Za Zhi 1995, 29:156-158.
80. Zoni S., Lucchini R.G. Manganese exposure: cognitive, motor and behavioral effects on children: a review of recent findings. Curr. Opin. Pediatr. 2013, 25:255-260.